Cosmos Health Issues Letter to Shareholders
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, With Gross Profit Rising 21%
Cosmos Health Files Secondary Offering of Shares
Cosmos Health Reports Robust Sales of Proprietary Brands on Amazon UK
Cosmos Health Reports 160% Increase In 2024 YTD Sales Of Proprietary Brands On Amazon UK, Reaching $596K Compared To $230K In 2023
Cosmos Health Gets Over $500,000 in UK Initial Orders for Antimicrobial Wash
Cosmos Health Receives Initial Orders Exceeding $500,000 For C-Scrub In The UK; Future Orders Booked At Accelerated Pace With Strong Profitability Anticipated Due To High Profit Margins
Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, With a Market Size Valued at Over $37.5 Billion
Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments
Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price
Cosmos Health Secures Exclusivity Agreement With Virax Biolabs to Distribute Mpox PCR Kits Across the GCC, Including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
Cosmos Health Regains Full Compliance With Nasdaq Listing Requirements
Sector Update: Health Care Stocks Edge Up Late Afternoon
Cosmos Health Shares Are Trading Higher After the Company Announced That, Pursuant to Its Agreement With Virax Biolabs, It Continues to Hold the Rights to Distribute Mpox Virus Real-time PCR Detection Kits, With Exclusive Distribution Rights in Greece...
Cosmos Health Signs Manufacturing Deal With Provident; Firm Holds EU Distribution Rights for Mpox Detection Kits
Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement With Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE
Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (Formerly Monkeypox) Virus Real-Time PCR Detection Kits
Cosmos Health Shares Are Trading Lower Following Quarterly Earnings.
Cosmos Holdings Reports Q1 Results
No Data
No Data